famotidine has been researched along with Carcinoma, Lobular in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Carcinoma, Lobular: A type of BREAST CANCER where the abnormal malignant cells form in the lobules, or milk-producing glands, of the breast.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty patients with breast cancer were prospectively randomized into case and control groups receiving 40 mg famotidine preoperatively for 10-14 days and routine premedication, respectively." | 9.10 | Does famotidine enhance tumor infiltrating lymphocytes in breast cancer? Results of a randomized prospective pilot study. ( Chattopadhyaya, TK; Gupta, SD; Kapoor, S; Kumar, A; Parshad, R, 2002) |
| "Thirty patients with breast cancer were prospectively randomized into case and control groups receiving 40 mg famotidine preoperatively for 10-14 days and routine premedication, respectively." | 5.10 | Does famotidine enhance tumor infiltrating lymphocytes in breast cancer? Results of a randomized prospective pilot study. ( Chattopadhyaya, TK; Gupta, SD; Kapoor, S; Kumar, A; Parshad, R, 2002) |
| "Current use of H(2) blockers overall, cimetidine, and famotidine was not associated with an increased risk of either invasive ductal or invasive lobular breast cancer." | 3.74 | Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer. ( Daling, JR; Li, CI; Malone, KE; Mathes, RW; Porter, PL, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parshad, R | 1 |
| Kapoor, S | 1 |
| Gupta, SD | 1 |
| Kumar, A | 1 |
| Chattopadhyaya, TK | 1 |
| Mathes, RW | 1 |
| Malone, KE | 1 |
| Daling, JR | 1 |
| Porter, PL | 1 |
| Li, CI | 1 |
1 trial available for famotidine and Carcinoma, Lobular
| Article | Year |
|---|---|
Does famotidine enhance tumor infiltrating lymphocytes in breast cancer? Results of a randomized prospective pilot study.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Breast Neoplasms; Carcinoma, Lobular; Case-Control Studies; F | 2002 |
1 other study available for famotidine and Carcinoma, Lobular
| Article | Year |
|---|---|
Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer.
Topics: Aged; Anti-Ulcer Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Case-Contr | 2008 |